Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Commonly Reported Research Observations Injection-site redness or irritation Temporary swelling or warmth sensation at the administration site Burning or stinging during administration Temporary skin sensitivity or irritation Mild headaches Temporary fatigue or tiredness Mild nausea Temporary itching or flushing sensations Temporary blue-tinted discoloration beneath the administration area in some research settings Copper-Related Research Considerations Because GHK-Cu is a copper-binding peptide, some research protocols may monitor for: Copper- and zinc-balance variability Increased sensitivity in higher-frequency protocols Temporary skin-related response variability Individual differences in antioxidant-response pathways Research involving prolonged or higher-frequency protocols commonly investigates the inclusion of: Zinc supplementation Vitamin C supplementation alongside GHK-Curelated research models
Sustained hyperglycaemia is linked to increased OxS and an increased risk of tissue damage
By reducing ROS and pro-inflammatory cytokines, it inhibits oxidative stress and inflammation, indirectly preventing HSC activation
Three peptides recommended for the 503A Bulks List so far today, after BPC-157 and KPV
Tiwari, M
US$ 21.42
US$ 25.39
US$ 25.60
US$ 24.26
US$ 23.54
US$ 24.75
US$ 25.20